Deep vein thrombosis (DVT) is a condition characterized by the formation a blood clot in the deep veins of the legs and affects nearly two million Americans per year. Clinical treatments for DVT include thrombolytic drugs and catheter-based surgical procedures, both of which have significant drawbacks, such as invasiveness and risks of bleeding and infection. Guided by ultrasound imaging, histotripsy is a cavitation-based ultrasound therapy that fractionates tissue. Using our laboratory prototype, histotripsy fractionated in vitro clots into debris smaller than red blood cells at a speed fifty-fold faster tan current clinical thrombolysis methods. Using an in vivo porcine DVT model, histotripsy non-invasively eradicated the thrombus in 10 of 12 cases. By eliminating thrombolytic drugs and catheters, shortening the treatment time, and maintaining or possibly increasing the efficacy for clot removal, histotripsy has the potential to truly change the landscape of thrombosis therapy. The goal of this proposal is to advance the clinical translation of histotripsy thrombolysis. To achieve this goal, we propose the following three specific aims. 1) Design and build an integrated image-guided histotripsy thrombolysis system for DVT patients. 2) Develop two technical innovations (microtripsy and bubble-induced color Doppler feedback) to further improve the safety and efficacy of histotripsy thrombolysis. 3) Determine the in vivo safety and efficacy of the clinically designed histotripsy thrombolysis system through a comprehensive pre-clinical study in the porcine DVT model.
These aims are designed to obtain results that are crucial towards achieving approval from the United States Food and Drug Administration (FDA) to inaugurate the first clinical trial of histotripsy thrombolysis. In addition, our proposed comprehensive preclinical in vivo safety study will quantitatively measure all the possible adverse effects of cavitation, which will be essential for clinical translation of all cavitation-bsed thrombolysis techniques including histotripsy. While we are currently studying DVT, there are many other diseases which could benefit from this revolutionary new thrombolysis technique, including stroke, myocardial infarction, superficial vein thrombosis, and peripheral arterial and graft thrombosis. Each poses a significant clinical problem where histotripsy thrombolysis may improve upon current treatment methods.

Public Health Relevance

Deep vein thrombosis (DVT) is a condition characterized by the formation a blood clot in the deep veins of the legs and affects nearly two million Americans per year. We propose to advance the clinical translation of histotripsy thrombolysis, a new non-invasive thrombolysis technique that has the potential to significantly improve the standard of care for DVT patients. There are many other diseases which could also benefit from this revolutionary thrombolysis technique, including stroke, myocardial infarction, superficial vein thrombosis, and peripheral arterial and graft thrombosis.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
2R01EB008998-06
Application #
8755293
Study Section
Biomedical Imaging Technology Study Section (BMIT)
Program Officer
Liu, Christina
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Biomedical Engineering
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Zhang, Xi; Owens, Gabe E; Cain, Charles A et al. (2016) Histotripsy Thrombolysis on Retracted Clots. Ultrasound Med Biol 42:1903-18
Miller, Ryan M; Zhang, Xi; Maxwell, Adam D et al. (2016) Bubble-Induced Color Doppler Feedback for Histotripsy Tissue Fractionation. IEEE Trans Ultrason Ferroelectr Freq Control 63:408-19
Vlaisavljevich, Eli; Greve, Joan; Cheng, Xu et al. (2016) Non-Invasive Ultrasound Liver Ablation Using Histotripsy: Chronic Study in an In Vivo Rodent Model. Ultrasound Med Biol 42:1890-902
Vlaisavljevich, Eli; Maxwell, Adam; Mancia, Lauren et al. (2016) Visualizing the Histotripsy Process: Bubble Cloud-Cancer Cell Interactions in a Tissue-Mimicking Environment. Ultrasound Med Biol 42:2466-77
Devanagondi, Rajiv; Zhang, Xi; Xu, Zhen et al. (2015) Hemodynamic and Hematologic Effects of Histotripsy of Free-Flowing Blood: Implications for Ultrasound-Mediated Thrombolysis. J Vasc Interv Radiol 26:1559-65
Vlaisavljevich, Eli; Lin, Kuang-Wei; Maxwell, Adam et al. (2015) Effects of ultrasound frequency and tissue stiffness on the histotripsy intrinsic threshold for cavitation. Ultrasound Med Biol 41:1651-67
Zhang, Xi; Jin, Lifang; Vlaisavljevich, Eli et al. (2015) Noninvasive thrombolysis using microtripsy: a parameter study. IEEE Trans Ultrason Ferroelectr Freq Control 62:2092-105
Zhang, Xi; Owens, Gabe E; Gurm, Hitinder S et al. (2015) Noninvasive thrombolysis using histotripsy beyond the intrinsic threshold (microtripsy). IEEE Trans Ultrason Ferroelectr Freq Control 62:1342-55
Vlaisavljevich, Eli; Xu, Zhen; Arvidson, Alexa et al. (2015) Effects of Thermal Preconditioning on Tissue Susceptibility to Histotripsy. Ultrasound Med Biol 41:2938-54
Zhang, Xi; Miller, Ryan M; Lin, Kuang-Wei et al. (2015) Real-time feedback of histotripsy thrombolysis using bubble-induced color Doppler. Ultrasound Med Biol 41:1386-401

Showing the most recent 10 out of 33 publications